Educational Dinner Event July 10th hosted by Mallinckrodt Pharmaceuticals
Greensleeves Steakhouse
220 Orange Street
Redlands, CA 92374
Thursday, July 10, 2025 at 6:30pm PT - 8:30pm PT
Add this event to your calendar
Info
Additional Information
Join us on the evening of July 10th as we learn about hepatorenal syndrome (HRS) and the first FDA approved treatment for HRS.
Dr. Mina Rakoski, Loma Linda University Transplant Institute, will explain the pathophysiology of hepatorenal syndrome (HRS), associated burden of disease, and current recommendations on diagnosis and treatment. Dr. Rakoski and the Mallinckrodt team will also explain the clinical data that led to the FDA approval of TERLIVAZ.
Hope to see you there!
Speakers
Register For This Event
Purchase of this ticket is for current members of the Inland Empire Chapter of AACN.
**Please note the vendor requires all guests attending this event to be a licensed healthcare provider. Proof of licensure will be required at checkout and at the time of the event. **
**As a courtesy to guests on the waiting list and to the vendor, we please ask you to notify the chapter via email at iecaacn@gmail.com as soon as possible if you can no longer attend this event. We thank you for your help ensuring education dinner events such as this one may continue in the future.**
Purchase of this ticket is a non-refundable/non-transferrable donation to the chapter. Your donation is appreciated.
*Please note the vendor requires all guests attending this event to be a licensed healthcare provider. Proof of licensure will be required at checkout and at the time of the event. **
**As a courtesy to guests on the waiting list and to the vendor, we please ask you to notify the chapter via email at iecaacn@gmail.com as soon as possible if you can no longer attend this event. We thank you for your help ensuring education dinner events such as this one may continue in the future.**